Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

R&D spending up 4% in Germany

by Alex Scott
November 21, 2016 | A version of this story appeared in Volume 94, Issue 46

R &D spending by Germany’s chemical and pharmaceutical industries is rising by about 4% per year and totals more than $11 billion annually, according to new data released by the German chemical industry organization VCI. That spending is equivalent to more than 5% of sales, the organization says. The number of chemical and drug company staffers working in R&D in Germany increased by about 3% in the past decade to a total of 42,000, VCI says. But the organization warns against complacency, noting that China’s share of global chemical research will hit 15% in 2030, up from less than 2% in 2000.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.